Arthritis, Juvenile Rheumatoid Clinical Trial
Official title:
A 12 Week Double-blind Randomized Trial, With a 12 Week Open-label Extension, to Investigate the Efficacy and Safety of Meloxicam Oral Suspension Administered Once Daily and Naproxen Oral Suspension Administered Twice Daily in Children With Juvenile Rheumatoid Arthritis
To obtain safety, efficacy, pharmacokinetic and dosing information for meloxicam oral suspension in children with Juvenile Rheumatoid Arthritis (JRA)
n/a
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00807846 -
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
|
Phase 4 | |
| Completed |
NCT00279747 -
A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA)
|
Phase 3 | |
| Completed |
NCT00652925 -
A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA
|
Phase 3 | |
| Completed |
NCT02001844 -
Foot Orthoses (FOs) on Pain, Quality of Life and the Gait With Children Diagnosed With JIA
|
N/A | |
| Completed |
NCT00731965 -
Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis
|
Phase 4 | |
| Completed |
NCT02067962 -
Identification of Genes Involved in Juvenile Idiopathic Arthritis by Wholel Exome Sequencing
|
N/A | |
| Terminated |
NCT00868751 -
Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis
|
N/A | |
| Terminated |
NCT00637780 -
Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis
|
Phase 4 | |
| Completed |
NCT00001614 -
The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis
|
Phase 1 | |
| Completed |
NCT01412021 -
Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis
|
||
| Enrolling by invitation |
NCT02377245 -
Juvenile Inflammatory Rheumatism (JIR) Cohorte
|
||
| Completed |
NCT00426218 -
Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06000566 -
Drug Compliance and Affecting Factors in Juvenile Idiopathic Arthritis
|
||
| Terminated |
NCT00511329 -
Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease
|
Phase 2/Phase 3 | |
| Terminated |
NCT00688545 -
Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis
|
||
| Recruiting |
NCT00012506 -
The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis
|
Phase 3 |